US Stock MarketDetailed Quotes

Immix Biopharma (IMMX)

Watchlist
  • 9.960
  • -0.080-0.80%
Close Apr 16 16:00 ET
  • 10.060
  • +0.100+1.00%
Post 20:01 ET
528.00MMarket Cap-11.19P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Immix Biopharma (IMMX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-63.96%-23.93M
-647.16%-11.03M
-46.32%-5.91M
-1.02%-5.31M
55.97%-1.69M
-28.35%-14.6M
44.87%-1.48M
-30.76%-4.04M
-49.52%-5.26M
-82.93%-3.83M
Net income from continuing operations
-35.67%-29.44M
-122.11%-10.69M
-6.10%-7.59M
-50.31%-6.62M
14.79%-4.54M
-39.13%-21.7M
6.66%-4.81M
-64.58%-7.15M
-22.45%-4.41M
-113.41%-5.33M
Depreciation and amortization
215.89%364.5K
119.25%90.63K
420.56%134.86K
228.61%79.84K
148.13%59.18K
2,010.24%115.39K
1,243.86%41.34K
1,775.89%25.91K
4,701.38%24.3K
4,622.77%23.85K
Change In working capital
-31.89%2.7M
-138.75%-1M
-54.34%1.07M
146.33%700.7K
259.31%1.93M
140.02%3.97M
81.80%2.59M
353.88%2.35M
-313.98%-1.51M
610.34%537.1K
-Change in receivables
311.99%2.06M
105.51%12.38K
-68.54%21.56K
-77.16%21.98K
319.80%2M
-8.74%-971.53K
51.76%-224.78K
118.03%68.54K
285.79%96.25K
-1,162.73%-911.54K
-Change in prepaid assets
-151.68%-286.73K
-134.99%-191.35K
-82.34%50.57K
-14.02%170.67K
33.62%-316.62K
396.03%554.77K
-47.20%546.84K
-35.90%286.41K
114.95%198.51K
-1,009.12%-476.99K
-Change in payables and accrued expense
-76.66%1.03M
-134.67%-790.86K
-48.26%1.04M
129.04%524.19K
-86.56%258.72K
80.80%4.4M
167.04%2.28M
342.69%2M
-292.53%-1.8M
908.74%1.92M
-Change in other current assets
--0
--0
--0
--0
--0
---20.42K
--0
--0
--0
---20.42K
-Change in other current liabilities
-3,536.40%-98.01K
-133.61%-33.37K
-1,450.40%-32.67K
-681.27%-16.14K
-174.27%-15.83K
--2.85K
---14.29K
---2.11K
---2.07K
--21.31K
Cash from discontinued investing activities
Operating cash flow
-63.96%-23.93M
-647.16%-11.03M
-46.32%-5.91M
-1.02%-5.31M
55.97%-1.69M
-28.35%-14.6M
44.87%-1.48M
-30.76%-4.04M
-49.52%-5.26M
-82.93%-3.83M
Investing cash flow
Cash flow from continuing investing activities
-512.54%-7.21M
-1,210.46%-6.65M
-37.16%-372.46K
-31.48%-127.63K
77.57%-67.71K
-2,160.90%-1.18M
-3,748.76%-507.15K
-597.84%-271.54K
-97.07K
-301.91K
Net PPE purchase and sale
37.77%-732.93K
67.44%-165.13K
-37.16%-372.46K
-31.48%-127.63K
77.57%-67.71K
-2,160.90%-1.18M
-3,748.76%-507.15K
-597.84%-271.54K
---97.07K
---301.91K
Net investment purchase and sale
---6.48M
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-512.54%-7.21M
-1,210.46%-6.65M
-37.16%-372.46K
-31.48%-127.63K
77.57%-67.71K
-2,160.90%-1.18M
-3,748.76%-507.15K
-597.84%-271.54K
---97.07K
---301.91K
Financing cash flow
Cash flow from continuing financing activities
573.33%107.39M
95.67M
10.61M
1.11M
0
3.14%15.95M
0
0
0
13,311.62%15.95M
Net common stock issuance
573.47%107.39M
--95.51M
--10.77M
--1.1M
--0
1.60%15.95M
--0
--0
--0
15,245.16%15.95M
Proceeds from stock option exercised by employees
5,168.86%131.14K
--124.8K
--516
--5.82K
--0
-4.93%2.49K
--0
--0
--0
--2.49K
Net other financing activities
---137K
--29.76K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
573.33%107.39M
--95.67M
--10.61M
--1.11M
--0
3.14%15.95M
--0
--0
--0
13,311.62%15.95M
Net cash flow
Beginning cash position
0.98%17.68M
-19.01%15.95M
-51.46%11.64M
-45.70%15.92M
0.98%17.68M
30.31%17.51M
0.55%19.69M
89.47%23.98M
155.77%29.32M
30.31%17.51M
Current changes in cash
43,272.74%76.24M
4,032.39%77.99M
200.52%4.33M
19.16%-4.33M
-114.83%-1.75M
-95.65%175.79K
5.73%-1.98M
-162.06%-4.31M
-555.07%-5.35M
699.05%11.82M
Effect of exchange rate changes
206.07%3.84K
53.26%-11.75K
-189.50%-20.55K
395.39%44.14K
22.82%-8K
-110.95%-3.62K
-180.31%-25.13K
295.07%22.96K
-36.97%8.91K
-1,744.48%-10.37K
End cash Position
431.21%93.93M
431.21%93.93M
-19.01%15.95M
-51.46%11.64M
-45.70%15.92M
0.98%17.68M
0.98%17.68M
0.55%19.69M
89.47%23.98M
155.77%29.32M
Free cash flow
-56.37%-24.66M
-464.44%-11.19M
-45.75%-6.28M
-1.58%-5.44M
57.55%-1.75M
-38.07%-15.77M
26.29%-1.98M
-37.82%-4.31M
-52.28%-5.35M
-97.36%-4.13M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -63.96%-23.93M-647.16%-11.03M-46.32%-5.91M-1.02%-5.31M55.97%-1.69M-28.35%-14.6M44.87%-1.48M-30.76%-4.04M-49.52%-5.26M-82.93%-3.83M
Net income from continuing operations -35.67%-29.44M-122.11%-10.69M-6.10%-7.59M-50.31%-6.62M14.79%-4.54M-39.13%-21.7M6.66%-4.81M-64.58%-7.15M-22.45%-4.41M-113.41%-5.33M
Depreciation and amortization 215.89%364.5K119.25%90.63K420.56%134.86K228.61%79.84K148.13%59.18K2,010.24%115.39K1,243.86%41.34K1,775.89%25.91K4,701.38%24.3K4,622.77%23.85K
Change In working capital -31.89%2.7M-138.75%-1M-54.34%1.07M146.33%700.7K259.31%1.93M140.02%3.97M81.80%2.59M353.88%2.35M-313.98%-1.51M610.34%537.1K
-Change in receivables 311.99%2.06M105.51%12.38K-68.54%21.56K-77.16%21.98K319.80%2M-8.74%-971.53K51.76%-224.78K118.03%68.54K285.79%96.25K-1,162.73%-911.54K
-Change in prepaid assets -151.68%-286.73K-134.99%-191.35K-82.34%50.57K-14.02%170.67K33.62%-316.62K396.03%554.77K-47.20%546.84K-35.90%286.41K114.95%198.51K-1,009.12%-476.99K
-Change in payables and accrued expense -76.66%1.03M-134.67%-790.86K-48.26%1.04M129.04%524.19K-86.56%258.72K80.80%4.4M167.04%2.28M342.69%2M-292.53%-1.8M908.74%1.92M
-Change in other current assets --0--0--0--0--0---20.42K--0--0--0---20.42K
-Change in other current liabilities -3,536.40%-98.01K-133.61%-33.37K-1,450.40%-32.67K-681.27%-16.14K-174.27%-15.83K--2.85K---14.29K---2.11K---2.07K--21.31K
Cash from discontinued investing activities
Operating cash flow -63.96%-23.93M-647.16%-11.03M-46.32%-5.91M-1.02%-5.31M55.97%-1.69M-28.35%-14.6M44.87%-1.48M-30.76%-4.04M-49.52%-5.26M-82.93%-3.83M
Investing cash flow
Cash flow from continuing investing activities -512.54%-7.21M-1,210.46%-6.65M-37.16%-372.46K-31.48%-127.63K77.57%-67.71K-2,160.90%-1.18M-3,748.76%-507.15K-597.84%-271.54K-97.07K-301.91K
Net PPE purchase and sale 37.77%-732.93K67.44%-165.13K-37.16%-372.46K-31.48%-127.63K77.57%-67.71K-2,160.90%-1.18M-3,748.76%-507.15K-597.84%-271.54K---97.07K---301.91K
Net investment purchase and sale ---6.48M------------------0----------------
Cash from discontinued investing activities
Investing cash flow -512.54%-7.21M-1,210.46%-6.65M-37.16%-372.46K-31.48%-127.63K77.57%-67.71K-2,160.90%-1.18M-3,748.76%-507.15K-597.84%-271.54K---97.07K---301.91K
Financing cash flow
Cash flow from continuing financing activities 573.33%107.39M95.67M10.61M1.11M03.14%15.95M00013,311.62%15.95M
Net common stock issuance 573.47%107.39M--95.51M--10.77M--1.1M--01.60%15.95M--0--0--015,245.16%15.95M
Proceeds from stock option exercised by employees 5,168.86%131.14K--124.8K--516--5.82K--0-4.93%2.49K--0--0--0--2.49K
Net other financing activities ---137K--29.76K--------------------------------
Cash from discontinued financing activities
Financing cash flow 573.33%107.39M--95.67M--10.61M--1.11M--03.14%15.95M--0--0--013,311.62%15.95M
Net cash flow
Beginning cash position 0.98%17.68M-19.01%15.95M-51.46%11.64M-45.70%15.92M0.98%17.68M30.31%17.51M0.55%19.69M89.47%23.98M155.77%29.32M30.31%17.51M
Current changes in cash 43,272.74%76.24M4,032.39%77.99M200.52%4.33M19.16%-4.33M-114.83%-1.75M-95.65%175.79K5.73%-1.98M-162.06%-4.31M-555.07%-5.35M699.05%11.82M
Effect of exchange rate changes 206.07%3.84K53.26%-11.75K-189.50%-20.55K395.39%44.14K22.82%-8K-110.95%-3.62K-180.31%-25.13K295.07%22.96K-36.97%8.91K-1,744.48%-10.37K
End cash Position 431.21%93.93M431.21%93.93M-19.01%15.95M-51.46%11.64M-45.70%15.92M0.98%17.68M0.98%17.68M0.55%19.69M89.47%23.98M155.77%29.32M
Free cash flow -56.37%-24.66M-464.44%-11.19M-45.75%-6.28M-1.58%-5.44M57.55%-1.75M-38.07%-15.77M26.29%-1.98M-37.82%-4.31M-52.28%-5.35M-97.36%-4.13M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -